Related Experiment Video

Updated: Jun 23, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

[Antioxidant status and restenosis after stenting of coronary arteries]

A I Kaminnyĭ, Iu A Shuvalova, V Z Lankin

    Kardiologiia
    |May 26, 2009
    PubMed

    Insights

    Antioxidant status may influence coronary artery restenosis after stenting. Higher levels of certain antioxidants correlate with better outcomes, while increased oxidative stress markers are linked to greater restenosis severity.

    Area of Science:

    • Cardiovascular Medicine
    • Biochemistry
    • Oxidative Stress Research

    Background:

    • Coronary artery restenosis remains a significant complication following percutaneous coronary intervention with stenting.
    • The role of oxidative stress and antioxidant status in restenosis pathogenesis requires further elucidation.

    Purpose of the Study:

    • To investigate the potential association between antioxidant status markers and the severity of coronary artery restenosis after transluminal coronary angioplasty with stenting.

    Main Methods:

    • Quantitative coronary angiography was performed 6 months post-stenting in men with ischemic heart disease.
    • Blood samples were analyzed for lipid peroxidation markers (lag phase, LDL lipoperoxides, MDA) and antioxidant enzyme activities (SOD, GP, catalase).

    Main Results:

    • Positive correlations were found between antioxidant markers (lag phase, GP activity) and minimal artery diameter post-stenting.
    • Conversely, markers of oxidative stress (LDL lipoperoxides, MDA) correlated positively with stenosis severity and negatively with minimal artery diameter.

    Conclusions:

    • Antioxidant status appears to play a role in modulating the degree of coronary artery restenosis after stenting.
    • These findings suggest that assessing oxidative stress markers could be valuable in predicting restenosis risk.
    Abstract

    Related Concept Videos

    Coronary Artery Disease V: Interprofessional Care01:27

    Coronary Artery Disease V: Interprofessional Care

    Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
    Acute Coronary Syndrome III: Diagnostic Studies01:30

    Acute Coronary Syndrome III: Diagnostic Studies

    Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
    Coronary Artery Disease II: Pathophysiology01:26

    Coronary Artery Disease II: Pathophysiology

    Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
    Acute Coronary Syndrome I: Introduction01:30

    Acute Coronary Syndrome I: Introduction

    Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
    Acute Coronary Syndrome IV: Interprofessional Care01:28

    Acute Coronary Syndrome IV: Interprofessional Care

    IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
    Atherosclerosis III: Management01:26

    Atherosclerosis III: Management

    Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...